PHILADELPHIA, PA -- (Marketwire) -- 09/14/09 -- ZaBeCor Pharmaceuticals ("ZaBeCor" or the
"Company") announced today the initiation of a Phase II clinical trial for
its asthma drug candidate Excellair, following the successful results of
the Company's Phase I clinical trials. ZaBeCor is one of the first
companies to deliver siRNA to the lung ... read more